Did Cephalon Pay James Mcmillen $101,650 to Help Promote Actiq for Off-Label Use?

In a recent post, I wondered why a doctor from Dillsberg, PA, a town with a total area of 0.8 square miles and only 2,063 people, would be the 5th highest...

Andy Grove Calls for Pharma “Wild Ducks.” Quack! Quack!

What stands in the way of more and faster success in getting cures to patients?Newsweek posed this question to Andy Grove, former CEO of Intel, in a recent interview ("A Research...

The Fake Avastin Supply Chain: China, Syria, Denmark, Switzerland, UK, US, Doctors

Authorities investigating the importation of low-cost foreign pharmaceuticals into the U.S. have identified a supply chain that may have allowed fake cancer drugs to reach U.S. clinics, according to investigators and...

Is FDA Seeking NSA Capabilities?

As reported by @AlecGaffney in Regulatory Focus (here), the "US Food and Drug Administration (FDA) recently issued a notice indicating that it is seeking the services of a company to help...

Dear Santa from Pharma: “Please, Sir, May I Have More?”

In the "Pharma's 2011 Christmas Wish List for Santa" survey, I had a list of items for Santa to deliver to the pharmaceutical industry. Naughty or nice, the drug industry did...

New PhRMA DTC Guidelines Ignore Elephant in Room: Moratorium

According to a press release issued today, the Pharmaceutical Research and Manufacturers of America (PhRMA) Board of Directors has adopted measures to strengthen the PhRMA Guiding Principles on Direct to Consumer...

How Many Adverse Event Reports Are Submitted to the FDA? Whatever the Answer, It’s...

I've been tracking the number of adverse event reports (AERs) submitted to the FDA over the years based on data supplied by the FDA here. The latest update of that data...

Are Pharma Marketers Drug Pushers?

"Critics may not like branded drugs pushed directly to consumers but it is clear that it brings people in the doctor's door," wrote Bob Ehrlich, Chairman of DTC Perspectives (see...

New Fangled Cardio Drugs: Good Lab Results, Little Benefit to Patients

In a story about the struggle of Amarin Pharmaceuticals against a "Fish Oil Backlash," Forbes blogger Matthew Herper said "the idea that some drugs may improve laboratory values without helping patients...

What Are Past Pharnaguy Social Media Pioneer Award Winners Doing Today?

Now that the 4th Annual Pharmaguy Social Media Pioneer Award winner will soon be announced, it's a good time to review who won the awards in 2010, 2011, and 2012 and...

Pharma Marketing News, Blog Posts, Events, Podcasts

- Advertisement -